|
D10: concomitant product: gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y gc-122 - gc-122 caprosyn* 3-0 und 75cm v20 x36, lot# d2e1153y.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
According to the reporter, during a veterinary procedure, it was noted that as soon as the customer took the 18 sutures out of the packaging, it tore immediately.The device was received without accompanying information.
|
|
Additional information: g3, h3, h6.H3 evaluation summary: medtronic conducted an investigation based upon all information received.Twenty sealed samples were available for evaluation.Visual inspection noted that a tactile and microscopic inspection of one suture was performed.The suture broke as it was being removed from the retainer.The break site of the suture was 4 1/8 inches from the needle attachment point.The suture also frayed at the needle attachment point when taking the measurement.It was reported that the suture was broken.The reported issue was confirmed.The most likely cause was determined to be manufacturing related.Internal process improvements have been initiated to mitigate this issue.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|